 |
|
Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis
J. Sastre-Garriga, MD;
G. T. Ingle, MRCP;
D. T. Chard, MRCP;
Lí. Ramió-Torrentà, MD;
M. A. McLean, PhD;
D. H. Miller, FRCP;
A. J. Thompson, FRCP
Arch Neurol. 2005;62:569-573.
Background Abnormalities in normal-appearing brain tissues may contribute to disability in primary progressive multiple sclerosis (PPMS), where few lesions are seen on conventional imaging.
Objectives To evaluate the mechanisms underlying disease progression in the early phase of PPMS by measuring metabolite concentrations in normal-appearing white matter (NAWM) and cortical gray matter (CGM) and to assess their relationship with clinical outcomes.
Design Case-control study.
Setting Tertiary referral hospital.
Patients Forty-three consecutive patients within 5 years of onset of PPMS and 44 healthy control subjects.
Main Outcome Measures Concentrations of choline-containing compounds, phosphocreatine, myo-inositol, total N-acetyl-aspartate (tNAA), and glutamate-glutamine were estimated using proton magnetic resonance spectroscopic imaging. Brain parenchymal, white matter and gray matter fractions and proton density and gadolinium-enhancing lesion loads were calculated. The Expanded Disability Status Scale and Multiple Sclerosis Functional Composite scores were recorded.
Results In CGM, concentrations of the tNAA (P<.001) and glutamate-glutamine (P = .005) were lower in patients with PPMS than in controls. In NAWM, myo-inositol levels were higher (P = .002) and tNAA levels were lower (P = .005) in patients with PPMS than in controls. The Expanded Disability Status Scale score correlated with the tNAA concentration in CGM (r = –0.44; P = .03) and with myo-inositol (r = 0.41; P = .01) and glutamate-glutamine concentrations (r = 0.41; P = .01) in NAWM. Proton density lesion load correlated negatively with CGM tNAA concentration and positively with NAWM myo-inositol concentration.
Conclusion Metabolite changes, which differ in CGM and NAWM, occur in early PPMS and are linked with disability.
Author Affiliations: Institute of Neurology, London, United Kingdom.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Magnetic resonance evidence of cortical onset of multiple sclerosis
Calabrese and Gallo
Mult Scler 2009;15:933-941.
ABSTRACT
Cortical lesions in primary progressive multiple sclerosis: A 2-year longitudinal MR study
Calabrese et al.
Neurology 2009;72:1330-1336.
ABSTRACT
| FULL TEXT
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
Rovaris et al.
Mult Scler 2008;14:455-464.
ABSTRACT
Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study
Sajja et al.
Mult Scler 2008;14:73-80.
ABSTRACT
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
De Stefano et al.
Neurology 2007;69:1942-1952.
ABSTRACT
| FULL TEXT
Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy
Wattjes et al.
Am. J. Neuroradiol. 2007;28:1517-1522.
ABSTRACT
| FULL TEXT
Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamus
Douglas et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R1254-R1259.
ABSTRACT
| FULL TEXT
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years
Rovaris et al.
Brain 2006;129:2628-2634.
ABSTRACT
| FULL TEXT
|
